Respiri Ltd (ASX: RSH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Respiri Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Respiri Ltd (ASX: RSH)
Latest News
No posts found.
RSH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Respiri Ltd
Respiri Ltd is a company engaged in the research, development, and commercialization of medical devices and the production of mobile health applications for the management of asthma and related chronic respiratory diseases. It operates through the following segments: The Australia segment includes research, development, and commercialisation of medical devices, and the production of mobile health applications in Australia. The company generates revenue through Medical Devices Segment in Australia.
RSH Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
24 Apr 2024 | $0.03 | $0.00 | 0.00% | 766,913 | $0.03 | $0.03 | $0.03 |
23 Apr 2024 | $0.04 | $0.00 | 0.00% | 368,421 | $0.04 | $0.04 | $0.04 |
22 Apr 2024 | $0.04 | $0.00 | 0.00% | 141,534 | $0.03 | $0.04 | $0.03 |
19 Apr 2024 | $0.03 | $0.00 | 0.00% | 318,775 | $0.03 | $0.03 | $0.03 |
18 Apr 2024 | $0.03 | $0.00 | 0.00% | 15,625 | $0.03 | $0.03 | $0.03 |
17 Apr 2024 | $0.03 | $0.00 | 0.00% | 110,534 | $0.03 | $0.03 | $0.03 |
16 Apr 2024 | $0.04 | $0.00 | 0.00% | 1,234,878 | $0.03 | $0.04 | $0.03 |
15 Apr 2024 | $0.03 | $0.00 | 0.00% | 140,000 | $0.03 | $0.03 | $0.03 |
12 Apr 2024 | $0.03 | $0.00 | 0.00% | 52,024 | $0.03 | $0.03 | $0.03 |
11 Apr 2024 | $0.03 | $0.00 | 0.00% | 187,584 | $0.03 | $0.03 | $0.03 |
10 Apr 2024 | $0.03 | $0.00 | 0.00% | 1,381,326 | $0.03 | $0.03 | $0.03 |
09 Apr 2024 | $0.03 | $0.00 | 0.00% | 51,771 | $0.03 | $0.03 | $0.03 |
08 Apr 2024 | $0.03 | $0.00 | 0.00% | 358,075 | $0.03 | $0.03 | $0.03 |
05 Apr 2024 | $0.03 | $0.00 | 0.00% | 303,030 | $0.03 | $0.03 | $0.03 |
04 Apr 2024 | $0.03 | $0.00 | 0.00% | 3,928,656 | $0.03 | $0.03 | $0.03 |
03 Apr 2024 | $0.03 | $0.00 | 0.00% | 612,012 | $0.03 | $0.03 | $0.03 |
28 Mar 2024 | $0.03 | $0.00 | 0.00% | 464,048 | $0.03 | $0.03 | $0.03 |
26 Mar 2024 | $0.03 | $0.00 | 0.00% | 631,600 | $0.03 | $0.03 | $0.03 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
21 Nov 2023 | Nicholas Smedley | Issued | 400,147 | $12,404 |
Placement.
|
21 Nov 2023 | Nicholas Smedley | Issued | 800,294 | $27,209 |
Placement.
|
01 Sep 2023 | Marjan Mikel | Cancelled | 30,000,000 | $930,000 |
As advised by the company. Cancellation of options
|
01 Sep 2023 | Nicholas Smedley | Cancelled | 30,000,000 | $930,000 |
As advised by the company. Cancellation of options at election of director
|
30 May 2023 | Brian Leedman | Buy | 620,068 | $22,942 |
On-market trade.
|
30 May 2023 | Brian Leedman | Buy | 620,068 | $229,425 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Marjan Mikel | Executive DirectorChief Executive OfficerManaging Director | Nov 2019 |
Mr Mikel is a managing director and board member with a career spanning Australia, Europe and Japan, Marjan's focus has been in the healthcare industry, from pharmaceuticals and information services and technology to medical devices and sleep disorder solutions. He founded and subsequently sold Healthy Sleep Solutions after developing it into a business, with Resmed Ltd as a joint venture/shareholder partner.
|
Mr Nicholas Smedley | Executive ChairmanExecutive Director | Oct 2019 |
Mr Smedley is an Investment Banker and M&A Advisor, with 14 years of experience at UBS and KPMG. He has worked on M&A transactions in the UK, Hong Kong, China, and Australia with transactions ranging from the A$9bn defence of WMC Resources through to the investment of $65m into Catch.com.au. Nicholas currently oversees investments in the Property, Aged care, Technology and Medical Technology space. Key areas of expertise include M&A, Debt structuring, corporate governance and innovation.
|
Dr Tamejiro (Tom) Takubo jr. | Non-Executive Director | Dec 2023 |
Dr Takubo also holds the position of Executive Vice President of Provider Relations at West Virginia University (WVU)
Health System where his clinical experience as a community-based Pulmonologist and Critical Care specialist provides strategic and practical insights into WVUHS clinical development direction and investments. He is responsible for helping build and manage new relationships and partnerships with external healthcare organizations and other businesses. He leads the development of innovative digital healthcare strategies for the organisation designed to introduce more effective, world leading healthcare aimed at improving patient health outcomes. WVUHS provides services throughout West Virginia, Ohio, Pennsylvania and Maryland and includes a network of hospitals with more than 1,800 beds and other health care institutions and services. |
Mr Justin Mouchacca | Joint Company Secretary | Jan 2024 |
-
|
Ms Nova Taylor | Joint Company Secretary | Jan 2024 |
-
|
Theo Antonopoulos | Chief Commercial Officer |
-
|
|
Peter Hildebrandt | Chief Operating Officer |
-
|
|
Samaneh Sarraf Shirazi | Chief Research Officer |
-
|
|
George Vlachodimitropoulos | Chief Technology Officer |
-
|
|
Justin Mouchacca | Joint Company Secretary |
-
|
|
Nova Taylor | Joint Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Netwealth Investments Limited <Wrap Services A/C> | 46,404,629 | 4.77% |
Netwealth Investments Limited <Super Services A/C> | 37,234,965 | 3.82% |
Bnp Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <Drp A/C> | 36,870,324 | 3.79% |
Citicorp Nominees Pty Ltimited | 20,950,208 | 2.15% |
Mallamanda Pty Ltd <Mallamanda A/C> | 18,032,352 | 1.85% |
Mr Peter Karl Braun | 18,026,140 | 1.85% |
Mrs Tara Marjorie Hill | 15,191,689 | 1.56% |
Obsidian Global Gp Llc | 14,314,150 | 1.47% |
Mr Simon Dumaresq and Dr Belinda Jackson <Dumason A/C> | 12,265,193 | 1.26% |
Mr John Anthony Dell | 10,500,000 | 1.08% |
Rosherville Pty Ltd <Ayton Super Fund A/C> | 9,800,000 | 1.01% |
Hsbc Custody Nominees (Australia) Limited | 9,276,059 | 0.95% |
Craft Law Pty Ltd <Forster Super Fund A/C> | 8,329,712 | 0.86% |
Mr Andre Szarukan and Ms Rose Braniska <The A & R Super Fund A/C> | 8,042,199 | 0.83% |
P & A Mihailou Pty Lts <Mihailou Family A/C> | 7,989,056 | 0.82% |
Mr Paul Argentino <Ap Investment Fund A/C> | 7,761,141 | 0.80% |
Mr Gary Ronald Heath and Mrs Melissa Louisse Heath <G & M Heath Superfund A/C> | 7,586,260 | 0.78% |
Torres Investments Pty Ltd | 7,424,070 | 0.76% |
Clemwell Pty Ltd <The Wells Family A/C> | 7,135,678 | 0.73% |
Dl Marshall Super Pty Ltd <Marshall Super Fund A/C> | 7,000,000 | 0.72% |